Clinical Trials Using XPO1 Inhibitor
Review the clinical trials studying xpo1 inhibitor on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.
You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.
Trials 1-18 of
18
- Status: ActiveLocation: 107 locations
- Status: ActiveLocation: 27 locations
- Status: ActiveLocation: 19 locations
- Status: ActiveLocation: 14 locations
- Status: ActiveLocation: 13 locations
- Status: ActiveLocation: 12 locations
- Status: ActiveLocation: 4 locations
- Status: ActiveLocation: 7 locations
- Status: ActiveLocation: 3 locations
- Status: ActiveLocation: 3 locations
- Status: ActiveLocation: 2 locations
- Status: ActiveLocation: University of Maryland/Greenebaum Cancer Center, Baltimore, Maryland
- Status: ActiveLocation: Mayo Clinic in Rochester, Rochester, Minnesota
- Status: ActiveLocation: Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee
- Status: ActiveLocation: See ClinicalTrials.gov
- Status: Temporarily Closed to AccrualLocation: 34 locations
- Status: Temporarily Closed to AccrualLocation: 2 locations
- Status: ActiveLocation: M D Anderson Cancer Center, Houston, Texas